Clinical Trials Monitor

About the Role

We are looking for a Quality Assurance Monitor to join a dynamic clinical trials unit supporting high quality clinical trials in primary care, psychiatry, women’s health, surgery and beyond. The Pragmatic Clinical Trials Unit (PCTU) is located in the Centre for Evaluation and Methods and linked with the Unit for Social and Community Psychiatry based in Newham.

You will work with the Quality Assurance team and the ChariotMS Trial Manager. You will be responsible for working alongside one other monitor in overseeing the unit’s regulated studies, primarily the ChariotMS study.

About You

The successful candidate will have experience in monitoring research studies, writing up detailed, clear reports and escalating findings appropriately. They will have a good knowledge of Good Clinical Practice, Data Protection guidelines and Clinical Trials Regulations.

About the School/Department/Institute/Project

The Wolfson Institute of Population Health (WIPH) is an exciting and dynamic environment, home to more than 450 staff, 100 PhD students and c500 postgraduate taught students. It harnesses expertise across a wide range of population-based research and education activities and aims to be an internationally recognised centre of excellence in population health, primary care and preventive medicine.

The post-holder will work in the Centre for Evaluation and Methods (CEM). CEM is a thriving centre that incorporates collaborative units who work to deliver outstanding research based on their combined and complementary strengths. The Centre comprises four units, including two UKCRC registered clinical trials units (CTUs): Barts CTU and the Pragmatic CTU; the Methodology Research Unit; and the Health Economics and Policy Research Unit. The post-holder will contribute to the work of the Pragmatic Clinical Trials Unit.

ChariotMS is a multi-centre, randomised, double-blind, placebo-controlled, phase IIb trial. The aim of the trial is to test oral cladribine (Mavenclad®) compared to placebo for safety, efficacy, and cost-effectiveness and to advance mechanistic understanding in people with advanced Multiple Sclerosis (MS). ChariotMS is the first ever disease modifying treatment (DMT) trial focussing on people with MS at this stage of disability.

About Queen Mary

At Queen Mary University of London, we believe that a diversity of ideas helps us achieve the previously unthinkable.

Throughout our history, we’ve fostered social justice and improved lives through academic excellence. And we continue to live and breathe this spirit today, not because it’s simply ‘the right thing to do’ but for what it helps us achieve and the intellectual brilliance it delivers.

We continue to embrace diversity of thought and opinion in everything we do, in the belief that when views collide, disciplines interact, and perspectives intersect, truly original thought takes form.

Benefits

We offer competitive salaries, access to a generous pension scheme, 30 days’ leave per annum (pro-rata for part-time/fixed-term), a season ticket loan scheme and access to a comprehensive range of personal and professional development opportunities. In addition, we offer a range of work life balance and family friendly, inclusive employment policies, flexible working arrangements, and campus facilities.

Queen Mary’s commitment to our diverse and inclusive community is embedded in our appointments processes. Reasonable adjustments will be made at each stage of the recruitment process for any candidate with a disability. We are open to considering applications from candidates wishing to work flexibly.